GUILLERMO
MAESTRO DE LA CALLE
Profesor asociado de Ciencias de la Salud
JOSÉ MARÍA
AGUADO GARCÍA
Catedrático de universidad
Publicaciones en las que colabora con JOSÉ MARÍA AGUADO GARCÍA (10)
2022
-
A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem
Internal and Emergency Medicine, Vol. 17, Núm. 2, pp. 515-524
-
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19
International Journal of Infectious Diseases, Vol. 117, pp. 56-64
2021
-
Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study
International Journal of Infectious Diseases, Vol. 105, pp. 487-494
-
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study
International Journal of Infectious Diseases, Vol. 105, pp. 319-325
-
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792
-
Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 6, pp. 1209-1216
-
Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination
PLoS Pathogens, Vol. 17, Núm. 12
-
Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study
Journal of Medical Virology, Vol. 93, Núm. 2, pp. 831-842
2020
-
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536
-
Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4